Product Description
Abamectin is a General Use Pesticide (GUP). It is classified as toxicity class IV - practically nontoxic, and has no precautionary statement on its label.
Mechanisms of Action: GABA Stimulant
Novel Mechanism: Yes
Modality: Large Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Chile | Pakistan
Approved Indications: None
Known Adverse Events: None
Company: National Institute for Medical Research, Tanzania
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Malaria
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT02533336 |
DL | P3 |
Terminated |
Malaria |
2016-08-31 |
2019-03-20 |
Treatments |